“…Furthermore, in a group of 13 German patients a marked antidepressant effect was reported after treatment with L-5-hydroxytryptophan (Sano and Taniguchi, 1972). On the other hand, in accordance with the case reported by Chouinard and Sultan (1992), Chase et al (1970Chase et al ( , 1972 reported a deterioration of parkinsonian symptoms after the addition of 5-hydroxytryptophan.…”
“…Furthermore, in a group of 13 German patients a marked antidepressant effect was reported after treatment with L-5-hydroxytryptophan (Sano and Taniguchi, 1972). On the other hand, in accordance with the case reported by Chouinard and Sultan (1992), Chase et al (1970Chase et al ( , 1972 reported a deterioration of parkinsonian symptoms after the addition of 5-hydroxytryptophan.…”
“…This idea is supported by results from case studies in which Parkinson's patients were treated with 5-HTP alone or in combination with peripheral decarboxylase inhibitors. There was a worsening in patient akinesia and rigidity with 5-HTP treatment that returned to the former state once 5-HTP treatment was stopped (Klein et al, 1986;Chase, 1970).…”
“…Patients with very low CSF 5-HIAA concentrations, who did not respond well to L-dopa, might represent a group in whom loss of 5-HT function is more important than loss of dopaminergic function. These particular patients might respond to treatment with 5-hydroxytryptophan despite evidence that this drug worsens Parkinsonism (Chase, 1970).…”
S U M M A R Y In Parkinson's disease, the concentration of homovanillic acid (HVA) was reduced in lumbar CSF from patients with idiopathic Parkinsonism (n=54, P<0.05) and post-encephalitic Parkinsonism (n=19, P
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.